"Complete response" letter from FDA should be addressed by the end of the year, firms state. read more
Advisory committee will consider whether the results for the non-Hodgkin's lymphoma treatment's Phase III trial, which suffered an unplanned early halt, are sufficient. read more
Statistics support the sense of financial analysts who have said there is pent-up need for basic colorectal and other cancer screening tests among the uninsured, which could be remedied through passage of health care reform legislation that extends insurance coverage to more Americans. read more
Public health officials want to build on inroads made with pregnant women and school children, but outside advisors warn that budgeting shortfalls threaten gains. read more
"The Pink Sheet" DAILY - Daily, in-depth analysis of the key developments shaping the biopharma industry. Not a subscriber? To register for a free trial, click here
